High Resolution Ultrasound in Pancreatic Ductal Adenocarcinoma
Not Applicable
Active, not recruiting
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Interventions
- Device: Ultrasound
- Registration Number
- NCT03820661
- Lead Sponsor
- University Health Network, Toronto
- Brief Summary
Pancreatic cancer patients at UHN who have had a CT at UHN and have surgery planned will undergo a high resolution ultrasound pre-operatively and intra-operatively. This study is being done to see if using high resolution ultrasound before and during surgery will help the doctors accurately diagnose pancreatic ductal adenocarcinoma and identify if the disease has spread to other areas of the body.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Males and females > 18 y
- PDAC diagnosed by typical imaging findings or pathology
- Scheduled for surgical resection
- Contrast enhanced CT scan performed locally at UHN
Read More
Exclusion Criteria
- Inability or unwillingness to provide informed consent
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description High Resolution Ultasound Ultrasound Diagnostic high resolution ultrasound pre-operatively and intraoperatively
- Primary Outcome Measures
Name Time Method High-resolution U/S will be used to measure vascular invasion and regional lymph node metastases in PDAC within 2 weeks of surgery The U/S results will be compared to pre-operative CT scan to help determine the diagnostic effectiveness of High Resolution US
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Health Network
🇨🇦Toronto, Ontario, Canada